Director Ferrari Richard purchases 62,500 shares of BEAT at $0.80 amid cluster buying; stock down 76.4% from 52-week high.
Director Ferrari Richard bought 62,500 shares at $0.80 on 2026-04-16, increasing his holdings by 27.3% to 291.6K shares. The purchase occurs in a cluster pattern—7 other insiders also bought within the past 14 days—which often reflects coordinated confidence or a response to an external catalyst. However, context is concerning: HeartBeam is unprofitable with net income of $-5.3M over its most recent full fiscal year, and the stock is trading -76.4% from its 52-week high and down 37.7% over the past 30 days. Richard's prior buy at this ticker in February 2025 generated a 90-day return of -7.4%, and his cross-ticker track record shows a 0.00% win rate on buys over the 90-day measurement period. The timing of this purchase against recent steep declines and the company's losses requires scrutiny into whether underlying fundamentals have stabilized or whether the cluster buying reflects desperation rather than conviction.
Director Ferrari Richard bought 29,412 shares of BEAT at $1.70 on 2025-02-14 ($50.0K); stock down -25.4% over 90 days amid -$5.0M net loss.
Ferrari Richard, a director, purchased 29,412 shares at $1.70, increasing his holdings by 19.6% to 179,136 shares post-transaction. The company reported a -$5.0M net loss over its most recent fiscal year and trades with a $55.5M market cap. The stock has declined -25.4% over the past 90 days and is trading -35.4% below its 52-week high of $3.22, creating a context of sustained downward momentum. The purchase occurred at a point of material weakness, but the underlying fundamentals remain negative, making the significance of this director-level accumulation moderate rather than a clear conviction signal.
